🇺🇸 FDA
Patent

US 11666666

Methods and compositions for modifying a mutant dystrophin gene in a cell's genome

granted A61KA61K48/0066A61K48/0091

Quick answer

US patent 11666666 (Methods and compositions for modifying a mutant dystrophin gene in a cell's genome) held by The Regents of the University of California expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K48/0066, A61K48/0091, A61P, A61P21/00